Status:
RECRUITING
Effects of Transcutaneous Electrical Phrenic Nerve Stimulation and Transcutaneous Electrical Diaphragmatic Stimulation
Lead Sponsor:
Hospital Sirio-Libanes
Collaborating Sponsors:
Hospital Israelita Albert Einstein
Conditions:
Diaphragm
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
Transcutaneous electrical phrenic nerve stimulation (TEPNS) and transcutaneous electrical diaphragm stimulation (TEDS) are modalities that use surface electrodes placed on the patients' skin to genera...
Detailed Description
This crossover trial, single-blind, bicentric study will be conducted at two hospitals. Adult volunteers aged 18 to 60 years, healthy, with a body mass index between 18.5 and 24.9 kg/m2, without a his...
Eligibility Criteria
Inclusion Criteria:
- Age between 18 and 60 years;
- Normal pulmonary function test, without alterations, assessed through spirometry;
- Body Mass Index (BMI) between 18.5 and 24.9 kg/m2.
Exclusion Criteria:
- Smokers or former smokers;
- Individuals with previously known cardiopulmonary diseases (restrictive lung diseases, chronic obstructive pulmonary disease - COPD, asthma, cystic fibrosis, among other pathologies);
- Presence of implanted electrical devices (pacemaker, implantable cardioverter-defibrillator, among others);
- Individuals who have contraindications to undergo evaluation and/or application of transcutaneous electrical stimulation of the diaphragm muscle, such as: altered sensitivity, wounds at the site of application, deformities, among other conditions.
Key Trial Info
Start Date :
April 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2026
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT06339632
Start Date
April 1 2024
End Date
March 1 2026
Last Update
April 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Sírio Libanês
São Paulo, São Paulo, Brazil, 01308-050